A state proposal to limit the number of drugs covered by Medicaid, fiercely opposed by patients and drug companies, has drawn national attention as states struggle to pay for costly new medicines.
A state proposal to limit the number of drugs covered by Medicaid, fiercely opposed by patients and drug companies, has drawn national attention as states struggle to pay for costly new medicines.